Orrstown Financial Services (ORRF) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
6 Nov, 2025Executive summary
Net income for Q3 2025 was $21.9 million ($1.13 per diluted share), up from $19.4 million in Q2 2025 and reversing a net loss of $7.9 million in Q3 2024, with profitability metrics at the high end of peers.
Return on average assets reached 1.60% and return on average equity was 15.72% for Q3 2025, both higher than the prior quarter.
Annualized loan growth reached 4.9% in Q3 2025, reflecting strong performance post-merger, with commercial loans up $38.2 million and residential mortgages up $10.3 million.
Fee income remained robust, accounting for nearly 21% of operating revenue for the second consecutive quarter.
No merger-related expenses were incurred in Q3 2025, compared to $1.0 million in Q2 2025.
Financial highlights
Net income for Q3 2025 was $21.9 million, with diluted EPS of $1.13, up from $1.01 in Q2 2025.
Net interest income reached $51.0 million, with net interest margin improving to 4.11% from 4.07% sequentially.
Noninterest income increased to $13.4 million from $12.9 million in Q2, nearly 21% of revenues.
Noninterest expenses declined by $1.3 million to $36.3 million, with efficiency ratio improving to 56.4% from 60.3%.
Tangible book value per share rose to $24.12 from $22.77.
Outlook and guidance
Net interest margin expected to remain in the 4.0% to 4.15% range, with minor impact from potential Fed rate cuts.
Loan growth guidance for next year is around 5%, with focus on CRE and middle market C&I.
Noninterest income projected at $48.0–$52.0 million annually; noninterest expenses at $142.0–$146.0 million.
Management expects continued benefits from the Codorus Valley merger, including expanded market reach and product offerings.
Management remains focused on prudent growth, credit quality, cost control, and capital adequacy amid economic uncertainty.
Latest events from Orrstown Financial Services
- Record earnings, strong loan growth, and higher dividend highlight robust 2025 results.ORRF
Q4 20253 Feb 2026 - Shelf registration allows up to $200M in securities for flexible corporate funding and growth.ORRF
Registration Filing29 Jan 2026 - Q1 2025 net income and EPS surged, with strong capital and lower merger costs.ORRF
Q1 202523 Dec 2025 - Major merger, robust financials, and key governance votes highlight this year's proxy.ORRF
Proxy Filing2 Dec 2025 - Q2 2025 saw higher earnings, improved efficiency, a dividend hike, and share repurchase authorization.ORRF
Q2 202516 Nov 2025 - Q3 2024 loss from merger costs offset by strong adjusted earnings and loan growth.ORRF
Q3 202413 Jun 2025 - Q2 net income declined, but dividend rose 15% and Codorus merger integration is on track.ORRF
Q2 202413 Jun 2025 - Q4 2024 net income rebounded, merger integration completed, and cost savings achieved.ORRF
Q4 20245 Jun 2025